OBJECTIVE: This study outlined the implementation and feasibility of delivering PROMIS®computer adaptive tests (CATs) using a web-based method to evaluate the impact of a technological adaptation of Cognitive-Behavioral Stress Management (CBSM) on the psychosocial functioning of men with advanced prostate cancer (APC) undergoing hormone therapy. METHOD: Patients were randomized to a CBSM group intervention (n = 95) or a health promotion (HP) attention-matched control condition (n = 97). Participants attended all sessions via video conference using tablets, and completed PROMIS®computer adaptive tests (CATs) assessing anxiety, depression, fatigue, pain interference, and physical function weekly during the 10-week intervention. RESULTS: Assessment completion rates >50% at week 1 and week 10 demonstrated moderate feasibility of repeatedly administering PROMIS® CATs using a web-based method. Multilevel modeling demonstrated no significant group-by-time interactions from week 1 to week 10 for any of the assessed PROMIS® domains adjusting for sociodemographic and medical covariates. However, simple effects demonstrated decreases in PROMIS®anxiety scores from week 1 to 10 for both groups. Results also demonstrated significant relationships of medical variables to psychosocial functioning across time points. CONCLUSIONS: Results highlight the feasibility and benefits of utilizing PROMIS® CATs to repeatedly assess psychosocial functioning using a web-based method and indicate that web-based interventions may be effective for decreasing psychosocial distress and adverse symptoms among men with APC undergoing hormone therapy. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
RCT Entities:
OBJECTIVE: This study outlined the implementation and feasibility of delivering PROMIS® computer adaptive tests (CATs) using a web-based method to evaluate the impact of a technological adaptation of Cognitive-Behavioral Stress Management (CBSM) on the psychosocial functioning of men with advanced prostate cancer (APC) undergoing hormone therapy. METHOD:Patients were randomized to a CBSM group intervention (n = 95) or a health promotion (HP) attention-matched control condition (n = 97). Participants attended all sessions via video conference using tablets, and completed PROMIS® computer adaptive tests (CATs) assessing anxiety, depression, fatigue, pain interference, and physical function weekly during the 10-week intervention. RESULTS: Assessment completion rates >50% at week 1 and week 10 demonstrated moderate feasibility of repeatedly administering PROMIS® CATs using a web-based method. Multilevel modeling demonstrated no significant group-by-time interactions from week 1 to week 10 for any of the assessed PROMIS® domains adjusting for sociodemographic and medical covariates. However, simple effects demonstrated decreases in PROMIS® anxiety scores from week 1 to 10 for both groups. Results also demonstrated significant relationships of medical variables to psychosocial functioning across time points. CONCLUSIONS: Results highlight the feasibility and benefits of utilizing PROMIS® CATs to repeatedly assess psychosocial functioning using a web-based method and indicate that web-based interventions may be effective for decreasing psychosocial distress and adverse symptoms among men with APC undergoing hormone therapy. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
Authors: Lynne I Wagner; Julian Schink; Michael Bass; Shalini Patel; Maria Varela Diaz; Nan Rothrock; Timothy Pearman; Richard Gershon; Frank J Penedo; Steven Rosen; David Cella Journal: Cancer Date: 2014-11-06 Impact factor: 6.860
Authors: Frank J Penedo; Ivan Molton; Jason R Dahn; Biing-Jiun Shen; Dave Kinsinger; Lara Traeger; Scott Siegel; Neil Schneiderman; Michael Antoni Journal: Ann Behav Med Date: 2006-06
Authors: Arnold L Potosky; William W Davis; Richard M Hoffman; Janet L Stanford; Robert A Stephenson; David F Penson; Linda C Harlan Journal: J Natl Cancer Inst Date: 2004-09-15 Impact factor: 13.506
Authors: David P Kinsinger; Frank J Penedo; Michael H Antoni; Jason R Dahn; Suzanne Lechner; Neil Schneiderman Journal: Psychooncology Date: 2006-11 Impact factor: 3.894
Authors: Thi Xuan Mai Tran; Jungeun Park; Joonki Lee; Yuh-Seog Jung; Yoonjung Chang; Hyunsoon Cho Journal: Support Care Cancer Date: 2020-10-15 Impact factor: 3.603
Authors: Frank J Penedo; Rina S Fox; Laura B Oswald; Patricia I Moreno; Cody L Boland; Ryne Estabrook; Heather L McGinty; David C Mohr; Mark J Begale; Jason R Dahn; Sarah C Flury; Kent T Perry; Shilajit D Kundu; Betina Yanez Journal: Int J Behav Med Date: 2020-10
Authors: William Goodman; Anne-Marie Bagnall; Laura Ashley; Desiree Azizoddin; Felix Muehlensiepen; David Blum; Michael I Bennett; Matthew Allsop Journal: JMIR Cancer Date: 2022-02-17